| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |